Search

everythinglearnresearchcommunity

for

Search:↓

Retinoic acids temporarily change skin stem cells to a slower cycle and more differentiated state.

Energy healing treatment improved flutamide's solubility and stability, potentially enhancing its effectiveness for prostate cancer.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Bacillus amyloliquefaciens can boost root hair growth in some Arabidopsis plants, potentially improving agriculture.

AH-001 could be a safer and more effective treatment for hair loss.

CS12192 effectively treats alopecia areata with better safety than current options.

Researchers found markers that can tell if hair has been bleached, which could improve hair test accuracy.

The method effectively measures lipid changes and drug effects on skin follicles.

TPO antibodies can help identify hypothyroid patients who still have symptoms despite normal TSH levels.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Future work on macrolide antibiotic analysis will aim to enhance selectivity, sensitivity, and efficiency using advanced chromatographic methods.

Vitamin C derivative reduces hair loss-related protein in cells.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Mice with the ab gene have abnormal sebaceous gland development, affecting sebum production.

A new, simple, and accurate method was created to measure finasteride in tablets.

New methods reliably assess hair regrowth and scalp health in hair loss patients.

OCT can effectively diagnose different stages of hair loss non-invasively.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Adding a second method to PROTACs could improve cancer treatment.

Hair analysis can somewhat track past testosterone levels but is influenced by factors like hair washing, growth rate, sex, and hair color.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

TH antibodies in vitiligo and AA patients recognize the same protein parts.